These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18295490)

  • 1. Synthesis of curcumin mimics with multidrug resistance reversal activities.
    Um Y; Cho S; Woo HB; Kim YK; Kim H; Ham J; Kim SN; Ahn CM; Lee S
    Bioorg Med Chem; 2008 Apr; 16(7):3608-15. PubMed ID: 18295490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and multidrug resistance reversal activity of dihydroptychantol A and its novel derivatives.
    Sun B; Yuan HQ; Xi GM; Ma YD; Lou HX
    Bioorg Med Chem; 2009 Jul; 17(14):4981-9. PubMed ID: 19540127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R.
    Xiao H; Xiao Q; Zhang K; Zuo X; Shrestha UK
    Ann Hematol; 2010 Apr; 89(4):399-404. PubMed ID: 19756599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
    Ganta S; Amiji M
    Mol Pharm; 2009; 6(3):928-39. PubMed ID: 19278222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
    Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
    Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.
    Kawase M; Sakagami H; Motohashi N; Hauer H; Chatterjee SS; Spengler G; Vigyikanne AV; Molnár A; Molnár J
    In Vivo; 2005; 19(4):705-11. PubMed ID: 15999537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells.
    Docolomanský P; Fialová I; Barancík M; Rybár A; Breier A
    Gen Physiol Biophys; 2005 Dec; 24(4):461-6. PubMed ID: 16474189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD; Işeri OD; Gunduz U; Molnar J
    Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by 4-chloro-N-(3-((E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)phenyl)benzamide through the reversible inhibition of P-glycoprotein.
    Kim YK; Song YJ; Seo DW; Kang DW; Lee HY; Rhee DK; Han JW; Ahn CM; Lee S; Kim SN
    Biochem Biophys Res Commun; 2007 Mar; 355(1):136-42. PubMed ID: 17286965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
    Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.
    Jiménez-Alonso S; Pérez-Lomas AL; Estévez-Braun A; Muñoz Martinez F; Chávez Orellana H; Ravelo AG; Gamarro F; Castanys S; López M
    J Med Chem; 2008 Nov; 51(22):7132-43. PubMed ID: 18954040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of some taxoids as multidrug resistance modulator.
    Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
    Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
    In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
    Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
    Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
    Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.
    Das U; Kawase M; Sakagami H; Ideo A; Shimada J; Molnár J; Baráth Z; Bata Z; Dimmock JR
    Bioorg Med Chem; 2007 May; 15(10):3373-80. PubMed ID: 17383883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.
    Fong WF; Wang C; Zhu GY; Leung CH; Yang MS; Cheung HY
    Phytomedicine; 2007 Feb; 14(2-3):160-5. PubMed ID: 16713217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.